Gastroenterology & Hepatology

Why it matters

Gastrointestinal and liver presentations often cross infectious disease, nutrition, oncology, maternal care, emergency care, and medication safety. WHO hepatitis and cancer-control guidance emphasizes screening, monitoring, linkage to care, prevention, and continuity rather than isolated test results.

InBasket AI keeps this care-domain pathway connected to one continuous patient record so a small care team can work from a single, trustworthy source of truth — part of expanding access to care for the next billion people.

Designed with reference to recognized global, national, and clinical standards

This care area is designed with reference to a standards ecosystem, including global guidance, national protocols, specialty-society recommendations, interoperability standards, and programme reporting requirements where applicable:

• WHO viral hepatitis guidance
• AASLD / EASL liver-disease guidance where locally adopted
• WHO nutrition and malnutrition guidance where applicable
• National hepatitis, liver-function monitoring, endoscopy, referral, and cancer-screening protocols
• National Ministry of Health standard treatment guidelines, essential medicines lists, and local scope-of-practice rules for the implementation setting
• HL7 FHIR, ICD-10, LOINC, SNOMED CT, and local terminology/coding standards where adopted

Standards sources

These sources substantiate the standards named above. Implementation-specific national protocols are selected from official national or regional authorities during deployment.

1. [1]World Health Organization guidelines and publications
2. [2]Official national Ministry of Health protocols for the implementation setting — Implementation-specific: selected from the official national or regional authority during deployment.
3. [3]AASLD practice guidelines
4. [4]EASL clinical practice guidelines
5. [5]HL7 FHIR
6. [6]WHO ICD classifications
7. [7]LOINC
8. [8]SNOMED CT

Evidence sources

• WHO Hepatitis